(2025) 166:bqae167
In the 30-second ad campaign, Williams stresses that taking GLP-1s is not a shortcut, its science
The growth is driven by expanding therapeutic applications beyond diabetes, such as obesity and cardiovascular diseases
In adipose tissue, GLP-1 receptors are directly expressed and activation impacts apoptosis and preadipocyte proliferation, as well as fat deposition through regulation of lipolysis, fatty acid oxidation, and adipocyte differentiation
For example, carriers may require the presence of a certain BMI and/or a weight-related condition, and may not offer coverage until other treatment modalities have been excluded
For a 50-pound goal, that translates to 25 to 50 weeks of treatment at therapeutic dose, plus the escalation period